IDXX Latest Headlines

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST)

at www.tipranks.com (Tue, 3-Feb 9:03 AM)

Balanced Risk Profile and Slower Near-Term Margin Expansion Support Neutral Stance on Idexx Laboratories

at www.tipranks.com (Tue, 3-Feb 7:08 AM)

Idexx Laboratories: Strong Q4 Execution, Robust 2026 Outlook, and Expanding Diagnostics Platform Support Buy Rating

at www.tipranks.com (Mon, 2-Feb 9:26 PM)

Idexx Laboratories Earnings Call Highlights Resilient Growth

at www.tipranks.com (Mon, 2-Feb 7:04 PM)

Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday?

at www.benzinga.com (Mon, 2-Feb 1:40 PM)

Idexx Laboratories: Recurring Diagnostics Strength, Innovation Pipeline, and Pet Health Tailwinds Support Buy Rating

at www.tipranks.com (Mon, 2-Feb 9:06 AM)

Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY)

at www.tipranks.com (Mon, 2-Feb 9:03 AM)

Options Volatility and Implied Earnings Moves Today, February 02, 2026

at www.tipranks.com (Mon, 2-Feb 7:05 AM)

IDEXX Laboratories Non-GAAP EPS of $3.01 beats by $0.07, revenue of $1.09B beats by $20M

at seekingalpha.com (Mon, 2-Feb 6:32 AM)

Here are the major earnings before the open Monday

at seekingalpha.com (Sun, 1-Feb 6:00 PM)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 1

at www.tipranks.com (Sun, 1-Feb 4:15 AM)

IDEXX Laboratories Q4 2025 Earnings Preview

at seekingalpha.com (Fri, 30-Jan 8:29 AM)

IDEXX Laboratories Delivers Double-Digit Revenue and EPS Growth, Boosts Outlook for 2025

Market Chameleon (Mon, 3-Nov 11:16 AM)

IDEXX Laboratories Lifts 2025 Outlook as Diagnostics Drive Double-Digit Growth

Market Chameleon (Mon, 3-Nov 7:37 AM)